Background: Kaposi’s Sarcoma (KS) is an angioproliferative tumor caused by human herpesvirus 8 (HHV-8), prevalent in sub-Saharan Africa and strongly associated with HIV infection. Data on the molecular characteristics and immune microenvironment of KS in the Democratic Republic of the Congo (DRC) are limited. Objective: To characterize HHV-8 ORF73 viral load and immune cell infiltration patterns in KS lesions from eastern and western DRC. Methods: This case series included 43 histologically confirmed KS patients from 2015 to 2024. DNA was extracted from formalin-fixed, paraffin-embedded biopsies, and HHV-8 ORF73 copy number was quantified by qPCR. Immunohistochemistry for HHV-8 LANA-1, CD3, CD4, CD8, CD20, and CD68 was performed, followed by digital morphometric quantification using HALO software. Viral load and immune infiltration percentages were compared between regions. Results: HHV-8 ORF73 copy numbers ranged from 11.26 to 2.7 × 10? copies/μL DNA, with higher values observed in samples from eastern DRC. LANA-1 expression ranged from 2% to 69% positive cells. CD4+ T cells were the predominant infiltrate (mean 32.96%), followed by CD8+ T cells (18.97%) and macrophages (17.14%). B cells were sparse (2.64%). Positive correlations were observed between viral load and LANA-1 expression, as well as between viral load and T-cell infiltration. Conclusion: KS lesions in the DRC exhibit considerable heterogeneity in viral load and immune composition, with higher viral activity in the eastern region. Integrating molecular analysis with digital morphometric assessment can enhance diagnostic precision and inform therapeutic strategies, particularly in resource-limited settings.
References
[1]
Mbulaiteye, S.M., Biggar, R.J. and Goedert, J.J. (2006) Epidemiology of Kaposi’s Sarcoma in Sub-Saharan Africa. Current Opinion in Oncology, 18, 478-483.
[2]
Cesarman, E., Chang, Y., Moore, P.S., Said, J.W. and Knowles, D.M. (1995) Kaposi’s Sarcoma-Associated Herpesvirus-Like DNA Sequences in Aids-Related Body-Cavity-Based Lymphomas. NewEnglandJournalofMedicine, 332, 1186-1191. https://doi.org/10.1056/nejm199505043321802
[3]
Mulumba, L., Nkosi, P. and Kabamba, B. (2023) Molecular Profiling of HHV-8 in Kaposi’s Sarcoma Lesions: Insights from Sub-Saharan Africa. Virology Journal, 20, Article No. 45.
[4]
Johnston, C., Sarid, R., Koonin, E.V. and Cesarman, E. (2009) Mechanisms of Immune Evasion by Kaposi’s Sarcoma-Associated Herpesvirus. PLOS Pathogens, 5, e1000458.
[5]
Kambale, P., Mumbere, M. and Kalenga, B. (2022) Regional Variations in Kaposi’s Sarcoma and HIV Prevalence in the Democratic Republic of Congo. Pan African Medical Journal, 41, Article No. 150.
[6]
Malonga, F., Tsuala, L. and Mbongo, P. (2022) Impact of ART Coverage on Kaposi’s Sarcoma Incidence in Central Africa. BMCCancer, 22, Article No. 112.
[7]
Phipps, W., Hladik, W. and Mbulaiteye, S.M. (2014) Immune Cell Dynamics in HHV-8 Infection and Kaposi’s Sarcoma Pathogenesis. Frontiers in Immunology, 5, Article No. 660.
[8]
Mbulaiteye, S.M., Goedert, J.J. and Engels, E.A. (2006) Kaposi’s Sarcoma in HIV-Infected Populations of Sub-Saharan Africa. Current Opinion in Oncology, 18, 478-483.
[9]
Cesarman, E., Chang, Y. and Moore, P.S. (2019) Pathogenesis and Molecular Biology of Kaposi’s Sarcoma-Associated Herpesvirus. Nature Reviews Cancer, 19, 567-581.
[10]
Mulumba, L., Nkosi, P. and Kabamba, B. (2023) Molecular Characterization of ORF73 Gene Expression in Kaposi’s Sarcoma Lesions. Virology Journal, 20, Article No. 45.
[11]
Kambale, P., Mumbere, M. and Kalenga, B. (2022) Regional Variations in HIV Prevalence and Impact on Kaposi’s Sarcoma. Pan African Medical Journal, 41, Article No. 150.
[12]
Malonga, F., Tsuala, L. and Mbongo, P. (2022) Influence of ART Adherence on HHV-8 Replication and KS Lesion Severity. BMCCancer, 22, Article No. 112.
[13]
Phipps, W., Hladik, W. and Mbulaiteye, S.M. (2014) Macrophage Infiltration and Tumor Progression in Kaposi’s Sarcoma. Frontiers in Immunology, 5, Article No. 660.
[14]
Johnston, C., Sarid, R., Koonin, E.V. and Cesarman, E. (2009) T Cell Responses and Immune Evasion in HHV-8 Infection. PLOS Pathogens, 5, e1000458.